ImageneBio (IMA) Short Interest Ratio & Short Volume $13.80 -0.24 (-1.71%) As of 02:21 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImageneBio Short Interest DataImageneBio (IMA) has a short interest of 90,200 shares, representing 0.43% of the float (the number of shares available for trading by the public). This marks a 11.77% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 13,744 shares to cover all short positions.Current Short Interest90,200 sharesPrevious Short Interest80,700 sharesChange Vs. Previous Month+11.77%Dollar Volume Sold Short$120.87 thousandShort Interest Ratio1.0 Days to CoverLast Record DateJune 30, 2025Outstanding Shares4,020,000 sharesFloat Size20,950,000 sharesShort Percent of Float0.43%Today's Trading Volume6,768 sharesAverage Trading Volume13,744 sharesToday's Volume Vs. Average49% Short Selling ImageneBio? Sign up to receive the latest short interest report for ImageneBio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMA Short Interest Over TimeIMA Days to Cover Over TimeIMA Percentage of Float Shorted Over Time ImageneBio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202590,200 shares $120.87 thousand +11.8%0.4%1 $1.34 6/15/202580,700 shares $108.95 thousand +0.8%0.4%0.9 $1.35 5/31/202580,100 shares $94.52 thousand -30.8%0.5%0.8 $1.18 5/15/2025115,700 shares $127.27 thousand -10.2%0.7%1.2 $1.10 4/30/2025128,900 shares $163.70 thousand -2.9%0.9%1.1 $1.27 4/15/2025132,700 shares $151.28 thousand +16.5%1.0%1.2 $1.14 3/31/2025113,900 shares $145.79 thousand -24.9%0.8%0.9 $1.28 3/15/2025151,700 shares $203.28 thousand +8.7%1.1%0.7 $1.34 2/28/2025139,600 shares $187.06 thousand -9.4%1.0%0.6 $1.34 2/15/2025154,100 shares $229.61 thousand +34.1%1.1%0.7 $1.49 Get the Latest News and Ratings for IMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImageneBio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025114,900 shares $170.05 thousand -11.8%0.6%0.5 $1.48 1/15/2025130,200 shares $194.00 thousand +18.2%0.7%0.7 $1.49 12/31/2024110,200 shares $180.73 thousand +41.1%0.5%0.6 $1.64 12/15/202478,100 shares $128.87 thousand -13.8%0.3%0.5 $1.65 11/30/202490,600 shares $156.74 thousand +9.7%0.3%1.6 $1.73 11/15/202482,600 shares $139.59 thousand -36.4%0.3%1.6 $1.69 10/31/2024129,900 shares $222.13 thousand -12.1%0.4%2.6 $1.71 10/15/2024147,800 shares $252.74 thousand -28.6%0.5%2.5 $1.71 9/30/2024207,100 shares $358.28 thousand -23.9%0.7%3.1 $1.73 9/15/2024272,200 shares $460.02 thousand -13.5%0.9%1.9 $1.69 8/31/2024314,700 shares $538.14 thousand +0.4%1.1%1.9 $1.71 8/15/2024313,600 shares $526.85 thousand -10.8%1.1%1.1 $1.68 7/31/2024351,500 shares $590.52 thousand -10.7%1.5%1.2 $1.68 7/15/2024393,700 shares $669.29 thousand -70.2%1.7%1.2 $1.70 6/30/20241,320,000 shares $2.18 million -6.4%5.6%3.8 $1.65 6/15/20241,410,000 shares $2.47 million -9.0%6.0%4.6 $1.75 5/31/20241,550,000 shares $2.74 million +12.3%6.6%4.6 $1.77 5/15/20241,380,000 shares $1.84 million -9.2%5.9%4.3 $1.34 4/30/20241,520,000 shares $2.01 million +9.4%6.0%3.9 $1.32 4/15/20241,390,000 shares $1.78 million +11.2%5.5%3.3 $1.28 3/31/20241,250,000 shares $1.78 million +11.6%5.0%3.1 $1.42 3/15/20241,120,000 shares $1.76 million +15.0%4.5%2.9 $1.57 2/29/2024974,000 shares $1.39 million +47.0%3.9%2.8 $1.43 2/15/2024662,400 shares $967.10 thousand +18.4%2.6%2.1 $1.46 1/31/2024559,400 shares $749.60 thousand +30.5%2.0%2.1 $1.34 1/15/2024428,700 shares $780.23 thousand -9.3%1.5%2 $1.82 12/31/2023472,500 shares $930.83 thousand +28.8%1.7%2.3 $1.97 12/15/2023367,000 shares $722.99 thousand -60.9%1.3%1.8 $1.97 11/30/2023939,200 shares $1.36 million -8.8%3.6%5.2 $1.45 11/15/20231,030,000 shares $1.44 million -19.5%4.0%6 $1.40I'm confused (Ad)MarketBeat All Access gives you the same powerful tools the pros rely on—analyst upgrades and downgrades, advanced stock screeners, and real-time portfolio tracking. For a limited time, you can unlock everything for 5 weeks for only $5. No gimmicks. No restrictions. Just the insights you need.Unlock 5 weeks of MarketBeat All Access for only $5 10/31/20231,280,000 shares $5.16 million +1.6%4.1%14.3 $4.03 10/15/20231,260,000 shares $5.30 million +21.2%3.7%13.3 $4.21 9/30/20231,040,000 shares $4.50 million -1.0%3.8%11.4 $4.33 9/15/20231,050,000 shares $4.67 million +4.0%4.0%8.4 $4.45 8/31/20231,010,000 shares $4.69 million -3.8%4.3%8.1 $4.64 8/15/20231,050,000 shares $4.43 million +32.4%4.5%8.8 $4.22 7/31/2023793,000 shares $4.08 million +10.1%3.1%6.9 $5.15 7/15/2023720,400 shares $4.40 million +0.2%2.8%6.6 $6.11 6/30/2023719,100 shares $4.72 million +234.0%2.8%6.6 $6.56 6/15/2023215,300 shares $1.42 million -22.9%1.0%1.9 $6.60 5/31/2023279,400 shares $1.80 million -19.1%1.2%4 $6.45 5/15/2023345,200 shares $2.42 million -22.2%1.5%5.1 $7.00 4/30/2023443,700 shares $2.43 million -4.7%1.7%7 $5.48 4/15/2023465,600 shares $2.33 million +33.2%1.8%5.7 $5.00 3/31/2023349,500 shares $1.21 million +1.6%1.4%4.4 $3.45 3/15/2023344,000 shares $1.46 million +14.5%1.3%5.1 $4.25 2/28/2023300,400 shares $1.20 million -20.8%1.2%3.4 $4.01 2/15/2023379,400 shares $1.59 million -78.9%1.5%4.1 $4.20 1/31/20231,800,000 shares $7.67 million +6.5%9.3%16.6 $4.26 1/15/20231,690,000 shares $5.49 million +3.1%8.7%20.3 $3.25 12/30/20221,640,000 shares $4.36 million -3.0%8.4%19.4 $2.66 12/15/20221,690,000 shares $4.43 million -0.6%8.7%18.9 $2.62 11/30/20221,700,000 shares $3.79 million -0.6%8.7%16.7 $2.23 11/15/20221,710,000 shares $3.76 million +9.6%8.8%20 $2.20 10/31/20221,560,000 shares $4.29 million +1.3%6.0%21.5 $2.75 10/15/20221,540,000 shares $4.79 million -10.5%6.5%19.5 $3.11 9/30/20221,720,000 shares $6.11 million +3.0%7.2%17.1 $3.55 9/15/20221,670,000 shares $7.45 million +3.7%7.0%9.4 $4.46 8/31/20221,610,000 shares $7.65 million -5.3%6.8%7.4 $4.75 8/15/20221,700,000 shares $8.91 million -5.6%7.2%7.5 $5.24 7/31/20221,800,000 shares $9.11 million -11.8%10.5%7.2 $5.06 7/15/20222,040,000 shares $10.79 million -14.6%11.9%7.4 $5.29 6/30/20222,390,000 shares $10.59 million -15.9%13.9%8.2 $4.43 6/15/20222,840,000 shares $10.65 million +1.1%16.3%10.6 $3.75 5/31/20222,810,000 shares $10.96 million +3.3%16.1%15.7 $3.90 5/15/20222,720,000 shares $10.17 million +8.8%15.6%15.2 $3.74 4/30/20222,500,000 shares $9.70 million +8.2%10.6%14.7 $3.88 4/15/20222,310,000 shares $16.15 million -1.3%9.8%16.2 $6.99 3/31/20222,340,000 shares $14.27 million -5.7%9.9%17.3 $6.10 3/15/20222,480,000 shares $14.11 million -11.1%10.6%18.7 $5.69 2/28/20222,790,000 shares $17.05 million +5.3%N/A17 $6.11 2/15/20222,650,000 shares $26.39 million +8.2%N/A16.6 $9.96 1/31/20222,450,000 shares $23.84 million +17.2%N/A14.4 $9.73 1/15/20222,090,000 shares $23.76 million +10.6%N/A12.8 $11.37 12/31/20211,890,000 shares $23.70 million +29.5%N/A12.3 $12.54 12/15/20211,460,000 shares $21.99 million +16.8%N/A9.8 $15.06 11/30/20211,250,000 shares $17.88 million +7.8%N/A11.7 $14.31 11/15/20211,160,000 shares $18.79 million +6.4%N/A11.6 $16.20 10/29/20211,090,000 shares $11.72 million -5.2%N/A12.8 $10.75 10/15/20211,150,000 shares $13.93 million -12.2%N/A15.9 $12.11I'm confused (Ad)MarketBeat All Access gives you the same powerful tools the pros rely on—analyst upgrades and downgrades, advanced stock screeners, and real-time portfolio tracking. For a limited time, you can unlock everything for 5 weeks for only $5. No gimmicks. No restrictions. Just the insights you need.Unlock 5 weeks of MarketBeat All Access for only $5 9/30/20211,310,000 shares $16.53 million -14.4%N/A11.1 $12.62 9/15/20211,530,000 shares $18.51 million +1.3%N/A12.1 $12.10 8/31/20211,510,000 shares $19.43 million -2.6%N/A11.8 $12.87 8/13/20211,550,000 shares $16.71 million No ChangeN/A12.3 $10.78 IMA Short Interest - Frequently Asked Questions What is ImageneBio's current short interest? Short interest is the volume of ImageneBio shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 90,200 shares of IMA short. 0.43% of ImageneBio's shares are currently sold short. Learn More on ImageneBio's current short interest. What is a good short interest ratio for ImageneBio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMA shares currently have a short interest ratio of 1.0. Learn More on ImageneBio's short interest ratio. What is a good short interest percentage for ImageneBio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.43% of ImageneBio's floating shares are currently sold short. Is ImageneBio's short interest increasing or decreasing? ImageneBio saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 90,200 shares, an increase of 11.8% from the previous total of 80,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImageneBio's float size? ImageneBio currently has issued a total of 4,020,000 shares. Some of ImageneBio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImageneBio currently has a public float of 20,950,000 shares. How does ImageneBio's short interest compare to its competitors? 0.43% of ImageneBio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImageneBio: Alector, Inc. (7.47%), GENFIT S.A. Unsponsored ADR (0.07%), Adherex Technologies Inc. (5.56%), Aerovate Therapeutics, Inc. (21.72%), Entrada Therapeutics, Inc. (5.13%), Sagimet Biosciences Inc. (12.47%), Innate Pharma S.A. Sponsored ADR (0.11%), ProQR Therapeutics N.V. (0.39%), AC Immune (2.44%), Monopar Therapeutics Inc. (3.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short ImageneBio stock? Short selling IMA is an investing strategy that aims to generate trading profit from ImageneBio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImageneBio? A short squeeze for ImageneBio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMA, which in turn drives the price of the stock up even further. How often is ImageneBio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMA, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies ALEC Short Interest GNFT Short Interest FENC Short Interest AVTE Short Interest TRDA Short Interest SGMT Short Interest IPHA Short Interest PRQR Short Interest ACIU Short Interest MNPR Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMA) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImageneBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImageneBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access